• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
48,502.41 -615.65
(-1.25%)
Dow Jones
6,987.82 -209.01
(-2.90%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.34 -0.08
(-0.09%)
EUR-INR
102.47 -0.06
(-0.06%)
GBP-INR
122.55 -0.48
(-0.39%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
432.1356994
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
40.03
114312.12
EPS(TTM)
Face Value()
Div & Yield %
35.35
2
0.92
 

Insilco reports standalone net loss of Rs 0.41 crore in the March 2026 quarter
Jun 01,2026
Net Loss of Insilco reported to Rs 0.41 crore in the quarter ended March 2026 as against net loss of Rs 1.23 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.76 crore in the year ended March 2026 as against net loss of Rs 2.83 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.